
Ali Ghasemzadeh, MD, PhD
@aghasemzadeh1
Urology PGY-5 @wiscurology | @hopkinsmedicine MSTP alum | interested in GU oncology, T cell biology, and antibodies.
ID: 947877681827328000
01-01-2018 17:10:24
56 Tweet
298 Followers
328 Following


Couldn’t be prouder to have worked with the Drake and Califano teams at Herbert Irving Comprehensive Cancer Center on this project, now out today in Cell. Special shout-out to first authors Aleks,Niv Chowdhury, and Scott Haake, MD, PhD for their hard work! authors.elsevier.com/c/1d5-5L7PXe~U…

How does one define exhaustion? As many have shown with ATACseq (E. John Wherry, Nick Haining, etc.), exhausted T cells are a lineage: posessing a relatively fixed chromatin landscape with unique accessible regions that define them the way Th1 vs Th2 are defined.



A new candidate vaccine against NMIBC in a multi institutional study in close collaboration with Trinity J. Bivalacqua Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against… disq.us/t/457gd6d

Cytoreductive Nephrectomy Following Immune Checkpoint Inhibitor Therapy Is Safe and Facilitates Treatment-free Intervals eu-openscience.europeanurology.com/article/S2666-… Daniel Shapiro Logan Zemp Viraj Master Wade J Sexton Ali Ghasemzadeh, MD, PhD Benjamin Schmeusser Facundo Davaro Surena F Matin MD Philippe spiess E Jason Abel



Results from our Ph2 study using Durva in BCG Unresponsive CIS is online Clinical Cancer Research 👉2/17 CR at 6mo 👉1/17 Gr 3 hepatotoxicity 👉1/17 PD-L1 high pre-treatment doi.org/10.1158/1078-0… #JingsongZhang Wade J Sexton Philippe spiess @sgilbert1973 Julio Pow-Sang #JRCG Moffitt Urologic Oncology Fellowship



Platinum-based chemotherapy is the standard of care for previously untreated unresectable or metastatic urothelial carcinoma, w/ cisplatin-based chemotherapy preferred for eligible pts. Full CheckMate 901 trial Research Summary by Michiel van der Heijden et al.: nej.md/3FmKbO6



Great job to our UW Urologic Oncology UW Urology students, residents, and fellow presenting their research at Wisconsin urological society meeting. No one moderates better than #MikeRisk


Thrilled to be headed to UrologyMSK for Society of Urologic Oncology fellowship! ari hakimi Couldn’t have done it without the support of all my mentors along the way E Jason Abel Daniel Shapiro Kyle A. Richards DJarrard Mike Risk Tudor Borza

From the March issue: Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer. brnw.ch/21wRkAK By Lisa Chesner, PhD, Felix Feng, Amy Moran Lab, and colleagues UCSF Helen Diller Family Comprehensive Cancer Ctr OHSU Knight Cancer Institute



Great job pgy5 Ali Ghasemzadeh, MD, PhD on your poster #AUA25! UW Urologic Oncology Society of Urologic Oncology E Jason Abel


